Biochemistry: Peptide ‘fingerprint’ enables earlier diagnosis of Alzheimer’s disease

Neurodegenerative diseases like Alzheimer’s disease or Parkinson’s disease are caused by folding errors (misfolding) in proteins or peptides, i.e. by changes in their spatial structure. This is the result of minute deviations in the chemical composition of the biomolecules. Researchers have now developed a simple and effective method for detecting such misfolding at an early stage of the disease. Misfolding is revealed by the structure of dried residue from protein and peptide solutions. The method involves analyzing micrographs with neural networks and has a predictive accuracy of over 99 percent.

Source: sciencedaily.com

Related posts

Tiny target discovered on RNA to short-circuit inflammation

‘Invisible tweezers’ use robotics and acoustic energy to achieve what human hands cannot

Genetic cause of rare childhood immune disorders discovered